Schmidt AW - Search Results

1

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley FD 3rd, Winston EN, Chen YL, Heym J. Schulz DW, et al. Among authors: schmidt aw. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10477-82. doi: 10.1073/pnas.93.19.10477. Proc Natl Acad Sci U S A. 1996. PMID: 8816826 Free PMC article.

2

The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review.

Seymour PA, Schmidt AW, Schulz DW. Seymour PA, et al. Among authors: schmidt aw. CNS Drug Rev. 2003 Spring;9(1):57-96. doi: 10.1111/j.1527-3458.2003.tb00244.x. CNS Drug Rev. 2003. PMID: 12595912 Free PMC article. Review.

3

Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active corticotropin-releasing factor 1 receptor antagonists.

Chen YL, Braselton J, Forman J, Gallaschun RJ, Mansbach R, Schmidt AW, Seeger TF, Sprouse JS, Tingley FD 3rd, Winston E, Schulz DW. Chen YL, et al. Among authors: schmidt aw. J Med Chem. 2008 Mar 13;51(5):1377-84. doi: 10.1021/jm070578k. Epub 2008 Feb 9. J Med Chem. 2008. PMID: 18260619

4

2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonists.

Chen YL, Obach RS, Braselton J, Corman ML, Forman J, Freeman J, Gallaschun RJ, Mansbach R, Schmidt AW, Sprouse JS, Tingley Iii FD, Winston E, Schulz DW. Chen YL, et al. Among authors: schmidt aw. J Med Chem. 2008 Mar 13;51(5):1385-92. doi: 10.1021/jm070579c. Epub 2008 Feb 21. J Med Chem. 2008. PMID: 18288792

5

Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.

Chen YL, Mansbach RS, Winter SM, Brooks E, Collins J, Corman ML, Dunaiskis AR, Faraci WS, Gallaschun RJ, Schmidt A, Schulz DW. Chen YL, et al. J Med Chem. 1997 May 23;40(11):1749-54. doi: 10.1021/jm960861b. J Med Chem. 1997. PMID: 9171885

6

The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.

Schmidt AW, McLean S, Heym J. Schmidt AW, et al. Eur J Pharmacol. 1992 Sep 4;219(3):491-2. doi: 10.1016/0014-2999(92)90498-s. Eur J Pharmacol. 1992. PMID: 1385177

7

8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production.

Sprouse J, Reynolds L, Li X, Braselton J, Schmidt A. Sprouse J, et al. Neuropharmacology. 2004 Jan;46(1):52-62. doi: 10.1016/j.neuropharm.2003.08.007. Neuropharmacology. 2004. PMID: 14654097

8

Serotonin-induced phase advances of SCN neuronal firing in vitro: a possible role for 5-HT5A receptors?

Sprouse J, Reynolds L, Braselton J, Schmidt A. Sprouse J, et al. Synapse. 2004 Nov;54(2):111-8. doi: 10.1002/syn.20070. Synapse. 2004. PMID: 15352136

9

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Seeger TF, Seymour PA, Schmidt AW, Zorn SH, Schulz DW, Lebel LA, McLean S, Guanowsky V, Howard HR, Lowe JA 3rd, et al. Seeger TF, et al. Among authors: schmidt aw. J Pharmacol Exp Ther. 1995 Oct;275(1):101-13. J Pharmacol Exp Ther. 1995. PMID: 7562537

10

CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor.

McLean S, Snider RM, Desai MC, Rosen T, Bryce DK, Longo KP, Schmidt AW, Heym J. McLean S, et al. Among authors: schmidt aw. Regul Pept. 1993 Jul 2;46(1-2):329-31. doi: 10.1016/0167-0115(93)90075-j. Regul Pept. 1993. PMID: 8210497 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page